Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Total Liabilities (2021 - 2025)

Lucid Diagnostics (LUCD) has disclosed Total Liabilities for 5 consecutive years, with $27.4 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Total Liabilities rose 68.28% year-over-year to $27.4 million, compared with a TTM value of $27.4 million through Sep 2025, up 68.28%, and an annual FY2024 reading of $25.3 million, down 14.39% over the prior year.
  • Total Liabilities was $27.4 million for Q3 2025 at Lucid Diagnostics, down from $30.8 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $38.2 million in Q1 2025 and bottomed at $4.3 million in Q4 2021.
  • Average Total Liabilities over 5 years is $21.1 million, with a median of $20.2 million recorded in 2024.
  • The sharpest move saw Total Liabilities tumbled 60.47% in 2022, then surged 212.63% in 2023.
  • Year by year, Total Liabilities stood at $4.3 million in 2021, then surged by 122.11% to $9.5 million in 2022, then soared by 212.63% to $29.6 million in 2023, then fell by 14.39% to $25.3 million in 2024, then grew by 8.05% to $27.4 million in 2025.
  • Business Quant data shows Total Liabilities for LUCD at $27.4 million in Q3 2025, $30.8 million in Q2 2025, and $38.2 million in Q1 2025.